92 related articles for article (PubMed ID: 24597668)
41. Secondary pulmonary alveolar proteinosis complicating myelodysplastic syndrome results in worsening of prognosis: a retrospective cohort study in Japan.
Ishii H; Seymour JF; Tazawa R; Inoue Y; Uchida N; Nishida A; Kogure Y; Saraya T; Tomii K; Takada T; Itoh Y; Hojo M; Ichiwata T; Goto H; Nakata K
BMC Pulm Med; 2014 Mar; 14():37. PubMed ID: 24597668
[TBL] [Abstract][Full Text] [Related]
42. Secondary pulmonary alveolar proteinosis: a single-center retrospective study (a case series and literature review).
Zhang D; Tian X; Feng R; Guo X; Wang P; Situ Y; Xiao Y; Xu KF
BMC Pulm Med; 2018 Jan; 18(1):15. PubMed ID: 29368649
[TBL] [Abstract][Full Text] [Related]
43. Secondary Pulmonary Alveolar Proteinosis Following Treatment with Azacitidine for Myelodysplastic Syndrome.
Hashimoto M; Itonaga H; Nannya Y; Taniguchi H; Fukuda Y; Furumoto T; Fujioka M; Kasai S; Taguchi M; Taniguchi H; Sato S; Sawayama Y; Atogami S; Iwasaki K; Hata T; Soda H; Moriuchi Y; Nakata K; Ogawa S; Miyazaki Y
Intern Med; 2020 Apr; 59(8):1081-1086. PubMed ID: 31875636
[TBL] [Abstract][Full Text] [Related]
44. Clinical features of three cases with pulmonary alveolar proteinosis secondary to myelodysplastic syndrome developed during the course of Behçet's disease.
Handa T; Nakatsue T; Baba M; Takada T; Nakata K; Ishii H
Respir Investig; 2014 Jan; 52(1):75-9. PubMed ID: 24388375
[TBL] [Abstract][Full Text] [Related]
45. Clinical features of secondary pulmonary alveolar proteinosis associated with myelodysplastic syndrome: Two case reports.
Liu Y; Chen LL; Qiu YY; Xiao YL; Cai HR
Medicine (Baltimore); 2017 Nov; 96(44):e8481. PubMed ID: 29095306
[TBL] [Abstract][Full Text] [Related]
46. Pulmonary alveolar proteinosis as a terminal complication in myelodysplastic syndromes: a report of four cases detected on autopsy.
Shoji N; Ito Y; Kimura Y; Nishimaki J; Kuriyama Y; Tauchi T; Yaguchi M; Payzulla D; Ebihara Y; Ohyashiki K
Leuk Res; 2002 Jun; 26(6):591-5. PubMed ID: 12007507
[TBL] [Abstract][Full Text] [Related]
47. Possible association of trisomy 8 with secondary pulmonary alveolar proteinosis in myelodysplastic syndrome.
Nishida A; Miyamoto A; Yamamaoto H; Uchida N; Izutsu K; Wake A; Ohta Y; Fujii T; Araoka H; Taniguchi S; Kishi K
Am J Respir Crit Care Med; 2011 Jul; 184(2):279-80. PubMed ID: 21765036
[No Abstract] [Full Text] [Related]
48. Cytogenetic response is not a prerequisite for clinical response in patients with myelodysplastic syndromes treated with azacitidine.
Gangatharan SA; Carney DA; Campbell LJ; Prince HM; Kenealy MK; Seymour JF
Eur J Haematol; 2011 Aug; 87(2):186-8. PubMed ID: 21623918
[No Abstract] [Full Text] [Related]
49. Clinical features of secondary pulmonary alveolar proteinosis: pre-mortem cases in Japan.
Ishii H; Tazawa R; Kaneko C; Saraya T; Inoue Y; Hamano E; Kogure Y; Tomii K; Terada M; Takada T; Hojo M; Nishida A; Ichiwata T; Trapnell BC; Goto H; Nakata K
Eur Respir J; 2011 Feb; 37(2):465-8. PubMed ID: 21282812
[No Abstract] [Full Text] [Related]
50. [A case of secondary pulmonary alveolar proteinosis associated with myelodysplastic syndrome, complicated with disseminated M. abscessus infection].
Asai Y; Ouchi H; Ohosima T; Nakano R; Yamano Y; Inoshima I; Yamauchi T; Fukuyama S; Inoue H; Nakanishi Y
Nihon Kokyuki Gakkai Zasshi; 2009 Dec; 47(12):1120-5. PubMed ID: 20058690
[TBL] [Abstract][Full Text] [Related]
51. Pulmonary alveolar proteinosis as a terminal complication in a case of myelodysplastic syndrome with idic(20q-).
Xue Y; Han Y; Li T; Chen S; Zhang J; Pan J; Wu Y; Wang Y; Shen J
Acta Haematol; 2010; 123(1):55-8. PubMed ID: 19955712
[TBL] [Abstract][Full Text] [Related]
52. Successful allogeneic bone marrow transplantation for myelodysplastic syndrome complicated by severe pulmonary alveolar proteinosis.
Tabata S; Shimoji S; Murase K; Takiuchi Y; Inoue D; Kimura T; Nagai Y; Mori M; Togami K; Kurata M; Ito K; Hashimoto H; Matushita A; Nagai K; Takahashi T
Int J Hematol; 2009 Oct; 90(3):407-412. PubMed ID: 19693450
[TBL] [Abstract][Full Text] [Related]
53. Secondary pulmonary alveolar proteinosis: a confusing and potentially serious complication of hematologic malignancy.
Chung JH; Pipavath SJ; Myerson DH; Godwin D
J Thorac Imaging; 2009 May; 24(2):115-8. PubMed ID: 19465834
[TBL] [Abstract][Full Text] [Related]
54. Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study.
Fenaux P; Mufti GJ; Hellstrom-Lindberg E; Santini V; Finelli C; Giagounidis A; Schoch R; Gattermann N; Sanz G; List A; Gore SD; Seymour JF; Bennett JM; Byrd J; Backstrom J; Zimmerman L; McKenzie D; Beach C; Silverman LR;
Lancet Oncol; 2009 Mar; 10(3):223-32. PubMed ID: 19230772
[TBL] [Abstract][Full Text] [Related]
55. Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelodysplastic syndromes.
Malcovati L; Germing U; Kuendgen A; Della Porta MG; Pascutto C; Invernizzi R; Giagounidis A; Hildebrandt B; Bernasconi P; Knipp S; Strupp C; Lazzarino M; Aul C; Cazzola M
J Clin Oncol; 2007 Aug; 25(23):3503-10. PubMed ID: 17687155
[TBL] [Abstract][Full Text] [Related]
56. Secondary pulmonary alveolar proteinosis associated with myelodysplastic syndrome.
Xie LX; Zhao TM; Wang QY; Chen LA; Li AM; Wang DJ; Qi F; Liu YN
Chin Med J (Engl); 2007 Jun; 120(12):1114-6. PubMed ID: 17637233
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
